FAIL (the browser should render some flash content, not this).
AdaBX
Abstract
New screening protocol optimized for the early selection of hybidomas generated with AdaGT selection media. AdaBX technology enables earlier isolation and stabilization of promising hybridomas by cell cloning. AdaBX screening is typically done 6-9 days after fusion.

Application(s)
Earlier and faster selection of hybidomas generated with AdaGT or HAT selection media.

Advantages
Earlier isolation of positive hybridomas enables earlier cell cloning and minimizes loss of positive hybridomas due to inherent genetic instability of these hybrid cells.

IP Status: Available both Exclusively and Non Exclusively.

Reference Number: 993

Internal Reference Number: A-013

Patents & Applications:
Application(s) Pending

Posted: 03-06-2007

Contact
Dr. Yinon Shlomi
contact@adarbiotech.com
Copyright © 2007 AdarBiotech.com. All Rights Reserved.
Contact Us | Site Map